Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Aug 10;313(7053):337-41.
doi: 10.1136/bmj.313.7053.337.

Perinatal characteristics in relation to incidence of and mortality from prostate cancer

Affiliations

Perinatal characteristics in relation to incidence of and mortality from prostate cancer

A Ekbom et al. BMJ. .

Abstract

Objective: To test the hypothesis that factors causing morbidity and mortality from prostate cancer may operate in utero.

Design: Matched case-control study of singleton men born between 1874 and 1946 at one hospital.

Setting: Uppsala University Hospital.

Subjects: 250 patients with prostate cancer and 691 controls, including 80 patients who died from prostate cancer and their 196 matched controls.

Main outcome measures: Mother's age at menarche, parity, pre-eclampsia or eclampsia before delivery, age at delivery and socioeconomic status; case or control's birth length and weight, placental weight, prematurity derived from gestational age, and presence of jaundice.

Results: Both pre-eclampsia (odds ratio 0, 95% confidence interval 0 to 0.71) and prematurity (0.31, 0.09 to 1.04) were inversely associated with incidence of prostate cancer. Among subjects born full term, placental weight, birth weight, and ponderal index (weight/height 3) showed non-significant positive associations with prostate cancer incidence, and stronger associations with mortality.

Conclusion: Prenatal exposures that are likely correlates of pregnancy hormones and other growth factors are important in prostate carcinogenesis and influence the natural course as well as the occurrence of this cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Cancer. 1995 Apr 10;61(2):177-80 - PubMed
    1. J Natl Cancer Inst. 1995 May 3;87(9):652-61 - PubMed
    1. J Natl Cancer Inst. 1995 May 3;87(9):662-9 - PubMed
    1. J Urol. 1993 Aug;150(2 Pt 1):379-85 - PubMed
    1. J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9 - PubMed

Publication types